Have a personal or library account? Click to login
Acute and delayed sulfur mustard toxicity; novel mechanisms and future studies Cover

Acute and delayed sulfur mustard toxicity; novel mechanisms and future studies

Open Access
|Nov 2010

References

  1. Adcock IM, Ito K, Barnes PJ. (2004) Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 1: 247-254.10.1513/pats.200402-001MS
  2. Balali-Mood M, Hefazi M. (2006) Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 99: 273-282.10.1111/j.1742-7843.2006.pto_429.x
  3. Barnes PJ. (2006) How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 148: 245-254.
  4. Bombail V, Moggs JG, Orphanides G (2004) Perturbation of epigenetic status by toxicants. Toxicol Lett 149: 51-58.10.1016/j.toxlet.2004.01.003
  5. Cui P, Luo Z, Zhang H, Su Y, Li A, Li H, Zhang J, Yang Z, Xiu R. (2006) Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells. J Pineal Res 41: 358-362.10.1111/j.1600-079X.2006.00375.x
  6. Deng WG, Tang ST, Tseng HP, Wu KK. (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108: 518-524.10.1182/blood-2005-09-3691
  7. Dugo L, Serraino I, Fulia F, De Sarro A, Caputi AP, Cuzzocrea S. (2001) Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation. J Pineal Res 31: 76-84.10.1034/j.1600-079X.2001.310111.x
  8. Emad A, Emad V. (2007) Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 240: 60-69.10.1016/j.tox.2007.07.014
  9. Emad A, Rezaian GR. (1999) Characteristics of bronchoalveolar lavage fluid in patients with sulfur mustard gas-induced asthma or chronic bronchitis. Am J Med 106: 625-628.10.1016/S0002-9343(99)00127-8
  10. Esposito E, Iacono A, Muia C, Crisafulli C, Mattace Raso G, Bramanti P, Meli R, Cuzzocrea S. (2008) Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 44: 78-87.
  11. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653.10.1056/NEJMoa03215815215480
  12. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-1976.10.1056/NEJMoa04189215888697
  13. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. (2001) Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. Faseb J 15: 1110-1112.10.1096/fsb2fj000432fje
  14. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM. (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203: 7-13.10.1084/jem.20050466211808116380507
  15. Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C. (1999) Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 50: 271-279.10.1093/toxsci/50.2.27110478864
  16. Jiang YH, Bressler J, Beaudet AL. (2004) Epigenetics and human disease. Annu Rev Genomics Hum Genet 5: 479-510.10.1146/annurev.genom.5.061903.18001415485357
  17. Kehe K, Raithel K, Kreppel H, Jochum M, Worek F, Thiermann H. (2007) Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Arch Toxicol [Epub ahead of print]10.1007/s00204-007-0265-718046540
  18. Kehe K, Szinicz L. (2005) Medical aspects of sulphur mustard poisoning. Toxicology 214: 198-209.10.1016/j.tox.2005.06.01416084004
  19. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. (2003) Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45: 1136-1143.10.1097/01.jom.0000094993.20914.d114610394
  20. Korkmaz A, Kurt B, Yildirim I, Basal S, Topal T, Sadir S, Oter S. (2008) Effects of Poly(ADP-Ribose) Polymerase Inhibition in Bladder Damage Caused by Cyclophosphamide in Rats. Exp Biol Med (Maywood) 233: 338-343.10.3181/0706-RM-15118296739
  21. Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S, Bilgic H. (2003) Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 170: 2498-2502.10.1097/01.ju.0000085593.31396.d814634459
  22. Korkmaz A, Oter S, Sadir S, Coskun O, Topal T, Ozler M, Bilgic H. (2005) Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats. J Urol 173: 1793-1796.10.1097/01.ju.0000154344.80669.e315821589
  23. Korkmaz A, Reiter RJ. (2008) Epigenetic regulation: a new research area for melatonin? J Pineal Res 44: 41-44.
  24. Korkmaz A, Topal T, Oter S. (2007) Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 23: 303-312.10.1007/s10565-006-0078-0
  25. Korkmaz A, Yaren H, Topal T, Oter S. (2006) Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol 80: 662-670.10.1007/s00204-006-0089-x
  26. Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ. (2001) Anti-angiogenic activity of melatonin in advanced cancer patients. Neuroendocrinol Lett 22: 45-47.
  27. Lopez LC, Escames G, Ortiz F, Ros E, Acuna-Castroviejo D. (2006) Melatonin restores the mitochondrial production of ATP in septic mice. Neuroendocrinol Lett 27: 623-630.
  28. Loppow D, Schleiss MB, Kanniess F, Taube C, Jorres RA, Magnussen H. (2001) In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 95: 115-121.10.1053/rmed.2000.0960
  29. Marwick JA, Kirkham PA, Stevenson CS, Danahay H, Giddings J, Butler K, Donaldson K, Macnee W, Rahman I. (2004) Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 31: 633-642.10.1165/rcmb.2004-0006OC
  30. McLachlan JA, Burow M, Chiang TC, Li SF. (2001) Gene imprinting in developmental toxicology: a possible interface between physiology and pathology. Toxicol Lett 120: 161-164.10.1016/S0378-4274(01)00295-8
  31. Mei Q, Yu JP, Xu JM, Wei W, Xiang L, Yue L. (2002) Melatonin reduces colon immunological injury in rats by regulating activity of macrophages. Acta Pharmacol Sin 23: 882-886.
  32. Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C. (2007) Cancer genetics of epigenetic genes. Hum Mol Genet 16 Spec No 1: R28-49.10.1093/hmg/ddm02117613546
  33. Moodie FM, Marwick JA, Anderson CS, Szulakowski P, Biswas SK, Bauter MR, Kilty I, Rahman I. (2004) Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. Faseb J 18: 1897-1899.10.1096/fj.04-1506fje15456740
  34. Oter S, Korkmaz A, Oztas E, Yildirim I, Topal T, Bilgic H. (2004) Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats. Urol Res 32: 185-189.10.1007/s00240-003-0398-y15205850
  35. Ozcan A, Korkmaz A, Oter S, Coskun O. (2005) Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats. Arch Toxicol 79: 461-465.10.1007/s00204-005-0647-715800758
  36. Rahman I, Marwick J, Kirkham P. (2004) Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaβ and proinflammatory gene expression. Biochem Pharmacol 68: 1255-1267.10.1016/j.bcp.2004.05.04215313424
  37. Reiter R, Gultekin F, Flores LJ, Terron MP, Tan DX. (2006) Melatonin: Potential Utility For Improving Public Health. Korhek 5: 131-158.10.5455/pmb.20060502131
  38. Reyes-Toso CF, Linares LM, Ricci CR, Aran M, Pinto JE, Rodriguez RR, Cardinali DP. (2004) Effect of melatonin on vascular reactivity in pancreatectomized rats. Life Sci 74: 3085-3092.10.1016/j.lfs.2003.10.03215081574
  39. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ. (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36: 1-9.10.1046/j.1600-079X.2003.00092.x
  40. Sadir S, Deveci S, Korkmaz A, Oter S. (2007) Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage to bladder tissue in rats. Cell Biochem Funct 25: 521-526.10.1002/cbf.134716850520
  41. Sasaki M, Jordan P, Joh T, Itoh M, Jenkins M, Pavlick K, Minagar A, Alexander SJ. (2002) Melatonin reduces TNF-α induced expression of MAdCAM-1 via inhibition of NF-kappaB. BMC Gastroenterol 2: 9.10.1186/1471-230X-2-911106212003644
  42. Sharma R, Ottenhof T, Rzeczkowska PA, Niles LP. (2008) Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. J Pineal Res [Epub ahead of print]10.1111/j.1600-079X.2008.00587.x18373554
  43. Somani SM, Babu SR. (1989) Toxicodynamics of sulfur mustard. Int J Clin Pharmacol Ther Toxicol 27: 419-435.
  44. Sourdeval M, Lemaire C, Deniaud A, Taysse L, Daulon S, Breton P, Brenner C, Boisvieux-Ulrich E, Marano F. (2006) Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 11: 1545-1559.10.1007/s10495-006-8764-116738803
  45. Tan DX, Manchester LC, Sainz RM, Mayo JC, Leon J, Hardeland R, Poeggeler B, Reiter RJ. (2005) Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin. J Pineal Res 39: 185-194.10.1111/j.1600-079X.2005.00234.x16098097
  46. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. (2007) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42: 28-42.10.1111/j.1600-079X.2006.00407.x17198536
  47. Tomas-Zapico C, Antonio Boga J, Caballero B, Vega-Naredo I, Sierra V, Alvarez-Garcia O, Tolivia D, Josefa Rodriguez-Colunga M, Coto-Montes A. (2005) Coexpression of MT1 and RORalpha1 melatonin receptors in the Syrian hamster Harderian gland. J Pineal Res 39: 21-26.10.1111/j.1600-079X.2005.00210.x15978053
  48. Tomas-Zapico C, Coto-Montes A. (2005) A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 39: 99-104.10.1111/j.1600-079X.2005.00248.x16098085
  49. Topal T, Oztas Y, Korkmaz A, Sadir S, Oter S, Coskun O, Bilgic H. (2005) Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res 38: 272-277.10.1111/j.1600-079X.2004.00202.x15813904
  50. Ucar M, Korkmaz A, Reiter RJ, Yaren H, Oter S, Kurt B, Topal T. (2007) Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 173: 124-131.10.1016/j.toxlet.2007.07.00517765411
  51. Wang H, Wei W, Shen YX, Dong C, Zhang LL, Wang NP, Yue L, Xu SY. (2004) Protective effect of melatonin against liver injury in mice induced by Bacillus Calmette-Guerin plus lipopolysaccharide. World J Gastroenterol 10: 2690-2696.10.3748/wjg.v10.i18.2690457219415309720
  52. Yaren H, Mollaoglu H, Kurt B, Korkmaz A, Oter S, Topal T, Karayilanoglu T. (2007) Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci 83: 116-122.10.1016/j.rvsc.2006.11.00417196628
  53. Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E. (2004) Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats. Cancer Chemother Pharmacol 54: 469-473.10.1007/s00280-004-0822-115232716
DOI: https://doi.org/10.2478/v10102-010-0027-x | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 22 - 26
Published on: Nov 1, 2010
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2010 Ahmet Korkmaz, Dun-Xian Tan, Russel Reiter, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.

Volume 1 (2008): Issue 1 (June 2008)